R35GM139531
Project Grant
Overview
Grant Description
Protein Networks as Synergistic Drivers of Membrane Remodeling - Summary Abstract:
Membrane curvature is required for many cellular processes, from assembly of highly curved trafficking vesicles to extension of needle-like filopodia. Consequently, defects in membrane curvature play a role in most human diseases, including altered recycling of receptors in cancer and diabetes, targeting of filopodia by pathogens, and hijacking of vesicle traffic during virus replication. Therefore, understanding the basic molecular mechanisms that drive membrane remodeling is essential to our knowledge of cellular physiology and human disease.
Research on membrane curvature has primarily focused on individual protein domains with specialized structures, such as crescent-shaped scaffolds and wedge-like amphipathic insertions. While this work has provided invaluable insights, this "structure-centric" perspective ignores two essential facts. First, most membrane remodeling proteins contain large intrinsically disordered domains in addition to structured domains. And second, these disordered domains drive assembly of large, multi-valent protein networks.
During the past 5 years, our group has made pioneering discoveries in support of the hypothesis that disordered protein networks are essential drivers of membrane remodeling in the cell. Specifically, using clathrin-mediated endocytosis as a model pathway, we showed that intrinsically disordered domains generate steric pressure at membrane surfaces. This pressure provides a surprisingly potent driving force for membrane bending, especially when coupled synergistically to the contributions of structured domains. This work was the first to reveal the membrane remodeling abilities of disordered proteins, examples of which have since been discovered in diverse areas of biology.
Additionally, we have recently found that disordered domains within endocytic proteins drive assembly of liquid-like protein networks which efficiently initiate endocytosis. Importantly, this liquid-like behavior has the potential to resolve a long-standing paradox by explaining how curved membrane structures can be simultaneously highly interconnected, yet dynamic and flexible.
These findings suggest urgent questions about the role of disordered protein networks in the key steps of membrane remodeling: (I) initiation, (II) curvature induction, and (III) cargo selection. First, how do protein networks initiate remodeling events, controlling their spatial and temporal dynamics? Second, once an event is initiated, how do protein networks bend membranes, stabilizing either a convex or a concave shape? Third, as the membrane bends, how does the protein network select cargo, such as transmembrane proteins, which are essential to the structure's biological function?
Building on our recent discoveries, this work will shift the paradigm for understanding membrane curvature beyond its present focus on in vitro structure-function relationships toward an understanding of disordered protein networks. By demonstrating novel synergistic mechanisms, this research will provide a blueprint for the study of protein networks at membrane surfaces throughout the cell.
Membrane curvature is required for many cellular processes, from assembly of highly curved trafficking vesicles to extension of needle-like filopodia. Consequently, defects in membrane curvature play a role in most human diseases, including altered recycling of receptors in cancer and diabetes, targeting of filopodia by pathogens, and hijacking of vesicle traffic during virus replication. Therefore, understanding the basic molecular mechanisms that drive membrane remodeling is essential to our knowledge of cellular physiology and human disease.
Research on membrane curvature has primarily focused on individual protein domains with specialized structures, such as crescent-shaped scaffolds and wedge-like amphipathic insertions. While this work has provided invaluable insights, this "structure-centric" perspective ignores two essential facts. First, most membrane remodeling proteins contain large intrinsically disordered domains in addition to structured domains. And second, these disordered domains drive assembly of large, multi-valent protein networks.
During the past 5 years, our group has made pioneering discoveries in support of the hypothesis that disordered protein networks are essential drivers of membrane remodeling in the cell. Specifically, using clathrin-mediated endocytosis as a model pathway, we showed that intrinsically disordered domains generate steric pressure at membrane surfaces. This pressure provides a surprisingly potent driving force for membrane bending, especially when coupled synergistically to the contributions of structured domains. This work was the first to reveal the membrane remodeling abilities of disordered proteins, examples of which have since been discovered in diverse areas of biology.
Additionally, we have recently found that disordered domains within endocytic proteins drive assembly of liquid-like protein networks which efficiently initiate endocytosis. Importantly, this liquid-like behavior has the potential to resolve a long-standing paradox by explaining how curved membrane structures can be simultaneously highly interconnected, yet dynamic and flexible.
These findings suggest urgent questions about the role of disordered protein networks in the key steps of membrane remodeling: (I) initiation, (II) curvature induction, and (III) cargo selection. First, how do protein networks initiate remodeling events, controlling their spatial and temporal dynamics? Second, once an event is initiated, how do protein networks bend membranes, stabilizing either a convex or a concave shape? Third, as the membrane bends, how does the protein network select cargo, such as transmembrane proteins, which are essential to the structure's biological function?
Building on our recent discoveries, this work will shift the paradigm for understanding membrane curvature beyond its present focus on in vitro structure-function relationships toward an understanding of disordered protein networks. By demonstrating novel synergistic mechanisms, this research will provide a blueprint for the study of protein networks at membrane surfaces throughout the cell.
Awardee
Funding Goals
THE NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES (NIGMS) SUPPORTS BASIC RESEARCH THAT INCREASES OUR UNDERSTANDING OF BIOLOGICAL PROCESSES AND LAYS THE FOUNDATION FOR ADVANCES IN DISEASE DIAGNOSIS, TREATMENT, AND PREVENTION. NIGMS ALSO SUPPORTS RESEARCH IN SPECIFIC CLINICAL AREAS THAT AFFECT MULTIPLE ORGAN SYSTEMS: ANESTHESIOLOGY AND PERI-OPERATIVE PAIN, CLINICAL PHARMACOLOGY ?COMMON TO MULTIPLE DRUGS AND TREATMENTS, AND INJURY, CRITICAL ILLNESS, SEPSIS, AND WOUND HEALING.? NIGMS-FUNDED SCIENTISTS INVESTIGATE HOW LIVING SYSTEMS WORK AT A RANGE OF LEVELSFROM MOLECULES AND CELLS TO TISSUES AND ORGANSIN RESEARCH ORGANISMS, HUMANS, AND POPULATIONS. ADDITIONALLY, TO ENSURE THE VITALITY AND CONTINUED PRODUCTIVITY OF THE RESEARCH ENTERPRISE, NIGMS PROVIDES LEADERSHIP IN SUPPORTING THE TRAINING OF THE NEXT GENERATION OF SCIENTISTS, ENHANCING THE DIVERSITY OF THE SCIENTIFIC WORKFORCE, AND DEVELOPING RESEARCH CAPACITY THROUGHOUT THE COUNTRY.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Texas
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 640% from $456,843 to $3,380,224.
University Of Texas At Austin was awarded
Synergistic Protein Networks Driving Membrane Remodeling
Project Grant R35GM139531
worth $3,380,224
from the National Institute of General Medical Sciences in February 2021 with work to be completed primarily in Texas United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.859 Biomedical Research and Research Training.
The Project Grant was awarded through grant opportunity Maximizing Investigators' Research Award (R35 - Clinical Trial Optional).
Status
(Ongoing)
Last Modified 8/20/25
Period of Performance
2/1/21
Start Date
1/31/26
End Date
Funding Split
$3.4M
Federal Obligation
$0.0
Non-Federal Obligation
$3.4M
Total Obligated
Activity Timeline
Transaction History
Modifications to R35GM139531
Additional Detail
Award ID FAIN
R35GM139531
SAI Number
R35GM139531-3319226500
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NS00 NIH National Institute of General Medical Sciences
Funding Office
75NS00 NIH National Institute of General Medical Sciences
Awardee UEI
V6AFQPN18437
Awardee CAGE
9B981
Performance District
TX-90
Senators
John Cornyn
Ted Cruz
Ted Cruz
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Institute of General Medical Sciences, National Institutes of Health, Health and Human Services (075-0851) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,440,008 | 100% |
Modified: 8/20/25